Daiichi Sankyo Aktie - D4S

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

22,25

Gebot

22,00

Fragen

22,50

Volumen

975

21,72 Tagesbereich 22,80

19,00 52-Wochen-Bereich 38,70

Handelsende

21,31

Handelsbeginn

21,80

Letzte Trade

22.8

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

3.467

Finanzvolumen

VWAP

Daiichi Sankyo and AstraZeneca secure EU approval for Datroway

Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer pat ...

Daiichi Sankyo and Astra launches Datroway in Japan for breast cancer

Daiichi Sankyo Co Ltd on Wednesday announced the launch of Datroway in Japan to treat breast cancer. The drug, with ...

Daiichi Sankyo sees 30% profit rise; names new chief executive officer

Daiichi Sankyo Co Ltd on Friday said it has seen profit growth of more than 30% in the year to date, as it upgrades i ...

AstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in US

AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday celebrated another approval of their cancer drug Enhertu. The Ca ...

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

AstraZeneca PLC on Monday said Datroway has been approved in the US for patients with a type of breast cancer. The C ...

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority ...

AstraZeneca and Daiichi withdraw EU application for lung cancer drug

AstraZeneca PLC and its Japanese partner Daiichi-Sankyo Co Ltd have withdrawn an application in the European Union fo ...

AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation

AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday announced they have been granted a breakthrough therapy designati ...

AstraZeneca "disappointed" as breast cancer drug blocked for NHS use

Women with incurable breast cancer in England and Wales will not be offered a life-extending drug on the national hea ...

TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China

AstraZeneca PLC on Monday said that its antibody drug conjugate Enhertu won another approval in China. The Cambridge ...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	2.100001	10.4218417083	20.149999	22.8	20.12	1735	20.71625048	DE
4	-0.33	-1.46147032772	22.58	23.48	19	1374	21.19715346	DE
12	-4.64	-17.2554853105	26.89	27.13	19	3467	22.8006436	DE
26	-6.76	-23.3023095484	29.01	31.8	19	2438	24.76458949	DE
52	-6.43	-22.419804742	28.68	38.7	19	1906	27.94186844	DE
156	-5.11	-18.6769005848	27.36	38.7	19	1519	28.02295082	DE
260	-5.11	-18.6769005848	27.36	38.7	19	1519	28.02295082	DE

D4S - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo share price?

The current share price of Daiichi Sankyo is 22,25 €

What is the 1 year trading range for Daiichi Sankyo share price?

Daiichi Sankyo has traded in the range of 19,00 € to 38,70 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WW6Ww International Inc	0,3468 € (169,88%)	144,1k
OYM1Odyssey Marine Exploration Inc	1,39 € (82,89%)	120,38k
VW5Cannabist Company Holdings Inc	0,0643 € (78,61%)	153,41k
Z620Trillion Energy International Inc	0,0307 € (48,31%)	103,45k
K8DWellfield Technologies Inc	0,0142 € (47,92%)	500
A07Avance Gas Holding Ltd	0,27 € (-46,80%)	1,26M
3SHShunfeng International Clean Energy Limited	0,0014 € (-36,36%)	3k
SQRSaia Inc.	216,00 € (-30,77%)	528
L7C2Windfall Geotek Inc	0,008 € (-30,43%)	32,29k
3PJ1Golden Dory Resourses	0,02 € (-25,93%)	40k
DMLSayona Mining Limited	0,0113 € (4,63%)	2,52M
11LCanopy Growth Corporation	1,222 € (-6,86%)	2,31M
PF8European Lithium Limited	0,0314 € (3,29%)	2,18M
D7GNel ASA	0,1982 € (-1,49%)	2,15M
3CPXiaomi Corporation	5,459 € (-1,83%)	1,56M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Daiichi Sankyo Co Ltd (D4S)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

D4S Neueste Nachrichten

Daiichi Sankyo and AstraZeneca secure EU approval for Datroway

Daiichi Sankyo and Astra launches Datroway in Japan for breast cancer

Daiichi Sankyo sees 30% profit rise; names new chief executive officer

AstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in US

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

AstraZeneca and Daiichi withdraw EU application for lung cancer drug

AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation

AstraZeneca "disappointed" as breast cancer drug blocked for NHS use

TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China

D4S - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Daiichi Sankyo Co Ltd (D4S) Börsenkurse

Daiichi Sankyo Co Ltd (D4S)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

D4S Neueste Nachrichten

Daiichi Sankyo and AstraZeneca secure EU approval for Datroway

Daiichi Sankyo and Astra launches Datroway in Japan for breast cancer

Daiichi Sankyo sees 30% profit rise; names new chief executive officer

AstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in US

AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

AstraZeneca and Daiichi withdraw EU application for lung cancer drug

AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation

AstraZeneca "disappointed" as breast cancer drug blocked for NHS use

TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China

D4S - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich für ein Konto unter ADVFN

Werbung entfernen